DRIVE trial; remote education and medication program; T2D

Increasing the use of SGLT2i and GLP-1RA with a remote program in T2D and high CV or kidney risk

Media formats available:

Details

Presenters

Comments

Overview
ACC.24 - Can the way patients are educated and medications prescribed be improved? Alexander Blood shares the results of the DRIVE study.
Educational information
This video was recorded in response to a presentation at the Congress of the American College of Cardiology (ACC) 2024.
Faculty
Alexander Blood, MD is cardiologist as well as a critical care physician at Brigham and Women's Hospital in Boston, MA, US.
Disclaimer
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
Read our summary of DRIVE
Release date: 10 april 2024

Presenters

Recommended

Details

Presenters

Comments

Overview
ACC.24 - Can the way patients are educated and medications prescribed be improved? Alexander Blood shares the results of the DRIVE study.
Educational information
This video was recorded in response to a presentation at the Congress of the American College of Cardiology (ACC) 2024.
Faculty
Alexander Blood, MD is cardiologist as well as a critical care physician at Brigham and Women's Hospital in Boston, MA, US.
Disclaimer
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
Read our summary of DRIVE
Release date: 10 april 2024

Presenters